Clinical significance of serum CYFRA 21-1 in patients with rapidly progressive interstitial lung disease

吴洁,肖永龙,蔡后荣,陈露露,周科峰,秦国初
DOI: https://doi.org/10.19460/j.cnki.0253-3685.2016.19.008
2016-01-01
Abstract:Objective To explore the significance of fragment of cytokeratin 19(CYFRA21-1) in evaluating the progression and prognosis of the patients with rapidly progressive interstitial lung disease(RP-ILD) .Methods Serum CYFRA21-1 was detected in the patients with RP-ILD(group A , 77 cases ) and the patients without RP-ILD (group C ,102 cases ) .The correlations between CYFRA21-1 levels and blood gas analysis ,radiologic characteristics and outcomes after treatment were analyzed .Results Serum level of CYFRA21-1 in group A was 9.13(6.5-13.49) ng/ml ,which was significantly higher than 3.81(2.39-6.23)ng/ml in group C(P<0 .05) .Serum level of CYFRA21-1 in group A was positively correlated with the radiologic parameters of the turbidity score of image lesion ,frosted glass shadow score ,severity score of the lesion ,and mesh focal range score(rs=0.604 , 0.661 ,0.634 and 0.621 ,P<0 .01) ,but negatively correlated with PaO2 (rs= -0 .266 ,P<0 .01) .The outcomes of group A after treatment were disease remission in 48 cases and death in 29 cases .Serum level of CYFRA21-1 was higher in the death cases than that in disease remission cases [13.44(10.46-15.51)ng/ml vs .6.41 (5.73-7.99) ng/ml](P<0 .05) .Conclusion Serum level of CYFRA21-1 is significantly increased in the patients with RP-ILD .CYFRA21-1 could be used as a serum marker to predict the severity and prognosis of the patients with RP-ILD .
What problem does this paper attempt to address?